In a web survey of 1,396 Chinese college students during COVID-19 quarantine, 52.3% had inadequate physical activity, and higher activity went with lower anxiety and depression scores (high activity and anxiety β = -0.121, P < 0.001). A single-time self-reported survey cannot show whether activity lowered symptoms or low mood reduced activity.
An overview of 150 Cochrane reviews found that exercise or physical activity was linked to a 13% lower risk of death (RR 0.87, 95% CI 0.78 to 0.96) and a small quality-of-life improvement (SMD 0.18, 95% CI 0.08 to 0.28). The prediction interval for mortality (0.70 to 1.07) includes no effect, so a new trial might not show a benefit.
In 95 French adults tested before, during and after lockdown, 19 reported improved well-being and showed lower heart rate and higher RMSSD, while the other 76 showed higher heart rate and lower RMSSD when lying down. This is a small convenience group of people who already did regular orthostatic tests, and the causes of the changes were not studied.
In a meta-analysis of 19 papers covering 841 older adults, mean anxiety scores fell from 38.7 ± 5.6 before exercise programs to 33.7 ± 3.4 afterward. The comparison is before versus after in the intervention group, not against a control group, so it cannot isolate the effect of exercise.
A narrative review of 82 papers (from 960 screened) found that medical wearables fall into 4 application areas: health and safety monitoring, chronic disease management, disease diagnosis and treatment, and rehabilitation. Because it is a narrative review that does not pool results, it maps what exists rather than showing how well any device works.
In an internet survey of 6,519 Italian adults during the COVID-19 lockdown, 3,562 (55.32%) reported poor sleep quality, and poor sleep went with female gender, changed sleep-wake timing and extremely severe stress, anxiety and depression. The sample was self-selected online and measured at one time, so it cannot show that lockdown or distress caused the poor sleep.
Using data from 11 448 adults in Italy, the authors built age- and sex-specific percentile curves for handgrip strength and the five-repetition chair-stand test, showing a rise to a peak at 18-24 years, preservation at 25-44 and decline from 45 onwards. Participants were volunteers recruited at exhibitions, malls and health campaigns, so they may not mirror the whole population.
Over 7 nights in 45 healthy adults, the Oura ring's total sleep time tracked a medical-grade actigraphy device closely (r=0.86), while the Samsung Gear Sport watch tracked it less well (r=0.59). Participants were healthy and wore the devices at home, so the results say little about people with sleep disorders or about sleep staging.
In a 16-week randomized trial of 244 overweight adults in Washington, DC, body weight fell by 5.9 kg (95% CI 5.0-6.7 kg; P < .001) on a low-fat vegan diet, with improved insulin sensitivity and less liver and muscle fat; none of these changed significantly in the control group. Participants knew their group and were mostly women (87%), so results may not apply to everyone.
In 543 healthy participants of the Baependi Heart Study in Brazil, time-domain heart rate variability (HRV) differed by age decade and sex, with higher values in men across almost all age groups. The reference values come from 24-hour Holter recordings in one rural, family-based cohort, so they may not match wrist-wearable readings or other populations.
Pooling 8 trials with 1657 participants, app-based interventions lowered systolic blood pressure by 2.28 mmHg (95% CI: between 0.66 and 3.90 lower) and improved medication adherence (standardized mean difference 0.38) in people with hypertension. The blood pressure drop is small, and only 6 of the 8 trials contributed to it.
In a national survey of 4551 US adults, about 30% (1266/4551) used wearable health devices, and use was linked to younger age, higher household income, exercise enjoyment and technology self-efficacy. The data are self-reported cross-sectional survey answers, so they describe who uses wearables, not why, and several estimates have wide confidence intervals.
Among 667 members of the Netherlands Sleep Registry, a quarter of people with pre-pandemic clinical insomnia had a meaningful improvement in sleep quality during lockdown, while 20% of pre-pandemic good sleepers slept worse. The sample was a self-selected registry assessed online, so the percentages describe these volunteers, not the Dutch population.
Among 1732 older adults with type 2 diabetes, 10.37% had sarcopenia, and metformin users had lower odds than people taking no medication (OR 0.510 for metformin alone, 0.398 combined with other drugs). This is a cross-sectional snapshot, so it cannot show that metformin protects muscle.
In 100 participants, a commercial smartwatch placed at different body positions agreed closely with a standard 12-lead ECG, with Cohen kappa 0.88 for ST elevation and 0.85 for non-ST elevation changes; sensitivity was 93% and 94% and specificity 95% and 92%. Only 81 people had a heart attack and 19 were healthy, and recordings were taken under supervised conditions, so this is not a test for use at home.
Pooling 7 cross-sectional studies, the estimated prevalence of sleep disturbances was 34.8% (95% CI 24.8-46.4%) among 3745 nurses and 41.6% (95% CI 27.7-57%) among physicians caring for COVID-19 patients. Heterogeneity was very high (I2 of 97.3% or higher), so these figures are broad estimates, not precise rates.
Using smartphone and wearable data from 1062 participants in five European countries, the authors detected lockdown-period changes in time at home, distance travelled, phone use, heart rate and sleep (most P<.001). The sample was a recruited research group, so the patterns may not represent each country's population.
In a trial of 140 hospitalized older adults with sarcopenia, a whey protein, leucine and vitamin D formula raised gait speed by 0.061 m/s per month versus -0.001 with placebo (difference 0.063 m/s/month, 95% CI 0.043 to 0.082, P < 0.001). It was a single-site trial, and results were analyzed in 127 patients who were reassessed at discharge.